MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

22 Apr 2022 Evaluate
A decrease in the sales to Rs. 52.92 millions was observed for the quarter ended March 2022. The sales stood at Rs. 61.45 millions during the similar quarter previous year.The Company to register a -58.43%  fall in the net profit for the quarter ended March 2022.Operating Profit reported a sharp decline to 4.55 millions from 5.57 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 52.92 61.45 -13.88 254.12 119.91 111.93 254.12 119.91 111.93
Other Income 2.05 1.37 49.64 6.73 4.60 46.30 6.73 4.60 46.30
PBIDT 4.55 5.57 -18.31 19.68 9.83 100.20 19.68 9.83 100.20
Interest 1.06 0.56 89.29 4.64 0.88 427.27 4.64 0.88 427.27
PBDT 3.49 5.01 -30.34 15.04 8.95 68.04 15.04 8.95 68.04
Depreciation 1.56 0.15 940.00 5.62 0.62 806.45 5.62 0.62 806.45
PBT 1.93 4.86 -60.29 9.42 8.33 13.09 9.42 8.33 13.09
TAX 0.45 1.30 -65.38 2.36 2.19 7.76 2.36 2.19 7.76
Deferred Tax 0.45 -0.01 -4600.00 2.34 -0.03 -7900.00 2.34 -0.03 -7900.00
PAT 1.48 3.56 -58.43 7.06 6.14 14.98 7.06 6.14 14.98
Equity 83.16 38.20 117.70 83.16 38.20 117.70 83.16 38.20 117.70
PBIDTM(%) 8.60 9.06 -5.15 7.74 8.20 -5.53 7.74 8.20 -5.53
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..